Impact of COVID-19 on Management and Outcomes of Oncology Patients: Results of MENA COVID-19 and Cancer Registry (MCCR).

Introduction: Despite extensive studies of the impact of COVID-19 on patients with cancer, there is a dearth of information from the Middle East and North Africa (MENA) region. Our study aimed to report pertinent MENA COVID-19 and Cancer Registry (MCCR) findings on patient management and outcomes.

Methods: MCCR was adapted from the American Society of Clinical Oncology COVID-19 Registry to collect data specifically from patients with cancer and SARS-CoV-2 infection from 12 centers in eight countries including Saudi Arabia, Jordan, Lebanon, Turkey, Egypt, Algeria, United Arab Emirates, and Morocco.

Peer-assisted versus expert-assisted learning in virtual chest x-ray interpretation: A randomized controlled trial.

Objectives: To compare the effectiveness of peer-assisted learning (PAL) and expert-assisted learning (EAL) in terms of knowledge gain in virtual chest x-ray (CXR) interpretations. The secondary objective was to assess students' satisfaction levels between both groups.

Methods: In this randomized controlled trial, second-year medical students who met the inclusion criteria were randomly assigned to the PAL and EAL groups.

Predictors of poor precautionary practices towards COVID-19 among cancer patients.

Our study goal was to evaluate the behavioral response and practices of cancer patients to the coronavirus disease 2019 (COVID-19) pandemic in the Middle East and north Africa. A cross-sectional study was conducted using a validated anonymous 45-question survey administered via SurveyMonkey to cancer patients in 13 centers in Algeria, Egypt, Jordan, Kuwait, Morocco and Saudi Arabia. During the study period (from 21 April to 30 May 2020), 3642 patients participated in the study.

The willingness of the Saudi Arabian population to participate in the COVID-19 vaccine trial: A case-control study.

Objectives: This study examines the Saudi Arabian population's willingness to participate in clinical trials for the coronavirus disease 2019 (COVID-19) vaccine, comparing recovered cases' willingness with that of healthy volunteers.

Methods: A case-control study was conducted on the Saudi Arabian population during September 2020. The data were collected from recovered COVID-19 participants as the case group, and healthy volunteers as the control group.